News

Office Hours for female VCs, founders expands to New York City

Scrum Ventures raises $19 mln of targeted $75 mln fund

Scrum Ventures has raised $19 million of a targeted $75 million third fund, according to a regulatory filing. The San Francisco-based firm is led by Tak Mitaya and makes early-stage investments in commerce, healthcare, Saas and IoT, according to its website. The filing lists four investors.

RiverVest to raise $150 mln fourth venture fund

RiverVest Venture Partners has set out to raise a $150 million fourth venture fund, according to a filing with the SEC.

Univercells nets $3.56 mln Series A

Univercells, a Belgian provider of biomanufacturing solutions, has raised $3.56 million in Series A funding. The investors included Takeda Ventures Inc.

Jnana Therapeutics scores $50 mln Series A

Boston-based Jnana Therapeutics Inc, which is focused on discovering drugs for cancer and other conditions by zeroing in on cellular proteins, has raised $50 million in Series A financing. The investors were Polaris Partners, Avalon Ventures, Versant Ventures, AbbVie Ventures and Pfizer R&D Innovate.

Deal counts in November drop across healthcare, IT, security and cleantech sectors

Andreessen Horowitz unveils $450 mln second bio fund

Fonds de solidarité FTQ creates Solunov to fund innovation ideas

The Fonds de solidarité FTQ has launched Solunov, a program to help identify, support and fund innovation by Québec businesses. Partnering with organizations like Inno Centre and Réseau TransTech, the Fonds will through Solunov assume up to 75 percent of the cost of innovation feasibility studies, up to a maximum of $250,000. It will also offer $1 million and up in unsecured, custom financing for emerging innovation projects. Based in Montréal, the $13.1-billion Fonds provides development capital to Québec companies.

Medical tech company Bay Labs attracts $5.5 mln Series A

San Francisco-based Bay Labs, a medical technology company, has closed $5.5 million in Series A funding. Khosla Ventures led the round with participation from other investors that included Data Collective, Greenbox Venture Partners, Minneapolis Heart Institute Ventures and Georges Harik. In conjunction with the funding, Ben Ling, a general partner at Khosla Ventures, and Armen Vidian, an operating partner at DCVC, will join Bay Labs’ board of directors.

Curisium snags $3.5 mln seed

Manhattan Beach, California-based Curisium, a healthcare technology and services company, has raised $3.5 million in seed financing. The backers were Flare Capital Partners, New Enterprise Associates, Shuttle Fund, Sanofi Ventures and Green Bay Ventures. In conjunction with the financing, Bill Geary of Flare Capital and Mohamad Makhzoumi of NEA have joined Curisium's board of directors while Ruchita Sinha of Sanofi Ventures has become a board observer.